Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
Follow us here
(click to enter)
“The things we hate about ourselves aren't more real than things we like about ourselves.” Ellen Goodman
Pharmacology Tutorials
Follow us here
Search This Blog
Posts
Labels
- ABCC11 (2)
- abctransporters (4)
- acetycholinesteraseinhibitors (1)
- adverseevents (3)
- alcohol (8)
- ALDH (1)
- alkaloids (2)
- atropinepoisoning (1)
- AUC (2)
- BAC (1)
- BBB (1)
- binge drinking (1)
- bioavailability (3)
- biomarkers (2)
- bodyweight (1)
- Boyanese (1)
- caffeine (4)
- cardiac (4)
- chemodefense (4)
- Chinese (5)
- cirrhosis (1)
- clarithromycin (5)
- clearance (5)
- clopidogrel (2)
- curcumin (1)
- cyp1a2 (4)
- CYP2C19 (2)
- CYP2C9 (4)
- CYP3A4/5 (7)
- CYP450 (1)
- CYP4F2 (1)
- death (3)
- distribution (5)
- doseresponse (7)
- drugmetabolism (10)
- drugresponse (3)
- durian (2)
- earwax (4)
- effect (9)
- effect-time (3)
- efficacy (16)
- elderly (1)
- environment (1)
- epigenetics (2)
- ethanol (1)
- ethnicity (14)
- extrapolation (1)
- first order (3)
- forensics (1)
- G6PDdef (1)
- gene-environment (4)
- geneticpolymorphism (3)
- grapefruit (3)
- halflife (4)
- hariraya (1)
- HERG (3)
- HLA (1)
- HWE (2)
- ibnsina (1)
- interactivegraph (2)
- intoxication (1)
- Japanese (1)
- Km (2)
- midazolam (1)
- misc (1)
- model (1)
- muscles (1)
- NAT2 (1)
- nature vs nurture (1)
- normality (2)
- olanzapine (1)
- optimization (15)
- personalizedmedicine (7)
- PGstuff (4)
- pharmacodynamics (7)
- pharmacogenetics (23)
- pharmacogenomics (5)
- pharmacokinetics (22)
- pharmacology (3)
- physostigmine (1)
- polyphenols (2)
- pomelo (1)
- populations (3)
- QTc (4)
- race (3)
- rbcs (1)
- reports (2)
- rofecoxib (1)
- rtwilliams (1)
- smoking (1)
- Startingoff (2)
- stress (1)
- Thais (1)
- theobromine (1)
- theophylline (1)
- time (1)
- toxicity (14)
- toxicokinetics (1)
- toxicology (1)
- transporters (8)
- UGT (2)
- variability (12)
- Vd (9)
- Vmax (2)
- warfarin (5)
- zero order (2)
- zero oredr (1)
Latest Results for Clinical Pharmacokinetics
- Pharmacokinetics and Safety of Levofloxacin for Treatment of Rifampicin-Resistant Tuberculosis During Pregnancy and the Postpartum Period: Results from IMPAACT P1026s
- Pharmacokinetics and Safety of Navitoclax in Hepatic Impairment
- Volume Kinetics of Gelofusine 4% During Vascular Surgery
- Leveraging Clinical Data to Enhance the Performance Evaluation of Ceftriaxone Population Pharmacokinetic Models in Children
- Correction: Influence of Ageing on the Pharmacodynamics and Pharmacokinetics of Chronically Administered Medicines in Geriatric Patients: A Review
Clinical Pharmacology & Therapeutics
- Optimizing Maternal and Fetal Antibody Exposure and Dosing Regimens During Pregnancy Using a Physiologically Based Pharmacokinetic Model
- Reply to “Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation”
- Use of Real‐World Claims Data to Assess the Prevalence of Concomitant Medications to Inform Drug–Drug Interaction Risk in Target Patient Populations
- Identification and Clinical Evaluation of Potential Biomarkers for Breast Cancer Resistance Protein (BCRP/ABCG2)
- Chat GPT and the Challenges to Detect Potential Drug–Drug Interactions Related to QT Prolongation
British Journal of Clinical Pharmacology
- EudraVigilance insights: Suspected adverse drug reactions in infants through breastfeeding
- Space travel‐associated motion sickness and its treatment
- Machine learning approach for dosage individualization of azithromycin in children with community‐acquired pneumonia
- Incidence and spectrum of typical complications associated with immunosuppressant use in rheumatic disease: A nationwide retrospective study
- Evaluation of the acute effects of single‐dose TPN171 on semen quality in healthy Chinese male volunteers
Drug Metabolism and Pharmacokinetics
- A procedure for method development and protein binding ratio as the indicator of sensitivity with anticancer agents on MALDI mass spectrometry imaging
- Ataluren metabolism: Ataluren-*O*-1β-acyl glucuronide is a stable circulating metabolite in mouse, rat, dog and human
- Identification of biomarkers to diagnose diseases and find adverse drug reactions by metabolomics
- Highly specific, quantitative polymerase chain reaction probe for the quantification of human cells in cynomolgus monkeys
- The utility of CYP3A activity endogenous markers for evaluating drug-drug interaction between sildenafil and CYP3A inhibitors in healthy subjects
The Pharmacogenomics Journal ( Current Issue)
- Impact of CYP2D6 polymorphisms on endoxifen concentrations and breast cancer outcomes
- Sulfotransferase 1A3/4 copy number variation is associated with neurodegenerative disease
- Pharmacogenomics study of thiazide diuretics and QT interval in multi-ethnic populations: the cohorts for heart and aging research in genomic epidemiology
- Effect of UMOD genotype on long-term graft survival after kidney transplantation in patients treated with cyclosporine-based therapy
- CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction
The Pharmacogenomics Journal ( Advance Online Publication)
- A feasibility study on *im*plementing pre-emptive *p*harmacogenomics *t*esting in outpatient clinics in Singapore (IMPT study)
- Cost-utility analysis of pharmacogenomics-guided tacrolimus treatment of Slovenian patients undergoing kidney transplantation in the U-PGx PREPARE study
- Integrating epidemiology and genomics data to estimate the prevalence of acquired cysteine drug targets in the U.S. cancer patient population
- CYP3A5 and POR gene polymorphisms as predictors of infection and graft rejection in post-liver transplant patients treated with tacrolimus - a cohort study
- Genetic markers of early response to lurasidone in acute schizophrenia
Articles from the PHG Foundation Newsletter
About Me
- PharmacoGenetics and Variability in Drug Response
- Singapore
- Edmund J.D. Lee
Help Build a school in Cambodia!
(click to enter)
My Other Blog: Cambodia Build a School Project
Total Pageviews
155983
pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenetics ethnicity singapore pharmacogenomics personalized medicine pharmacogenomics personalized medicine pharmacogenomics personalized medicine pharmacogenomics personalized medicine pharmacogenomics personalized medicine pharmacogenomics personalized medicine
No comments:
Post a Comment